HCV NS5B polymerase inhibitor

0 marketed 1 in Phase 3

This page covers all HCV NS5B polymerase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HCV NS5B RNA-dependent RNA polymerase.

Targets

HCV NS5B RNA-dependent RNA polymerase

Phase 3 pipeline (1)